CARM logo

CARM
Carisma Therapeutics Inc

38,772
Mkt Cap
$2.68M
Volume
829,916.00
52W High
$1.27
52W Low
$0.0261
PE Ratio
0.34
CARM Fundamentals
Price
$0.064
Prev Close
$0.056
Open
$0.046
50D MA
$0.1723
Beta
0.96
Avg. Volume
2.11M
EPS (Annual)
-$1.46
P/B
-3.08
Rev/Employee
$426,782.61
Loading...
Loading...
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
46

Frequently Asked Questions

What is Market Cap of Carisma Therapeutics Inc?
What is the 52-week high for Carisma Therapeutics Inc?
What is the 52-week low for Carisma Therapeutics Inc?
What is Carisma Therapeutics Inc stock price today?
What was Carisma Therapeutics Inc stock price yesterday?
What is the PE ratio of Carisma Therapeutics Inc?
What is the Price-to-Book ratio of Carisma Therapeutics Inc?
What is the 50-day moving average of Carisma Therapeutics Inc?
How many employess does Carisma Therapeutics Inc has?

Latest CARM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.